|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Pregnancies and terminations after 1995 warning about third-generation oral |
| Jick SS; Vasilakis C; Jick H |
| Lancet. 1998 May 9;351(9113):1404-5. |
| An October 1995 letter issued by the UK Medicines Control Agency warned that third-generation oral contraceptives |
| (OCs) containing gestodene or desogestrel may increase the risk of venous thromboembolism. The letter expressed |
| concern that the number of pregnancies and induced abortions would increase as a result of abrupt discontinuation |
| of these formulations. The validity of this concern was investigated in a retrospective review of data on cohorts of OC |
| users drawn from the General Practice Research Database. In the cohort of women who took OCs in the year before |
| October 1994, 74% of users of the third-generation OCs, and 77% of users of other OC formulations, continued use |
| after the 1995 warning. 4% and 8%, respectively, switched to another OC and 22% and 15%, respectively, terminated |
| OC use. In contrast, among the cohort that began OC use in the months prior to the October 1995 warning, 14% of |
| third-generation users, and 79% of other users, continued the same pill after the warning. 68% and 5%, respectively, |
| switched to another OC formulation; 18% and 16%, respectively, discontinued OC use. The 12-month frequencies of |
| pregnancies and pregnancy terminations did not differ significantly in the 1994 and 1995 cohorts in overall rates or by |
| type of OC, suggesting the warning was not associated with the feared abrupt termination of OC use and upswing in |
| unwanted pregnancies. (PubHealth.info Document ID: CONT2T 48-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Pregnancies and terminations after 1995 warning about |
| third-generation oral contraceptives [letter]", is(are) Jick SS; Vasilakis C; Jick H. The source of this article is |
| "Lancet. 1998 May 9;351(9113):1404-5.". This article was published in 1998 in English language(s). (PubHealth.info® |
| Document ID: CONT2T 48-06. All rights reserved with PubHealth.info) PIN: 5048 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |